NEW MALARIA TREATMENT INTRODUCED IN SOMALIA

2006-04-25 18:58
서울--(뉴스와이어)--4월 25일은 아프리카 말라리아의 날입니다. 아프리카에서만 5세 미만 어린이 1백만 명이 매년 말라리아로 사망합니다. 유니세프와 협력기관은 기존의 말라리아 처치방법을 개선하였습니다.

* * *

NEW MALARIA TREATMENT INTRODUCED IN SOMALIA
Africa Malaria Day boost for children and women

Nairobi, 25 April 2006 - A New effective treatment has been introduced in Somalia to curb the incidence of malaria which is one of the leading killers of children and women, UNICEF Somalia Representative, Christian Balslev-Olesen announced today on the occasion of Africa Malaria Day today.

An estimated one million children below five years die of malaria annually in Africa. In central and Southern Somalia, malaria is estimated to account for approximately 8% of all illnesses among children under-five years of age. The burden is highest along the rivers and settlements with artificial water reservoirs where there is all-year-round transmission.

“By introducing effective drugs for malaria treatment in Somalia, UNICEF and its partners will be addressing the challenge faced by children and women in combating malaria,” said Mr. Balslev-Olesen. “ The malaria burden is worst felt among children below five years and pregnant women who account for majority of the reported cases and deaths.

The policy shift from the traditional single-drug therapy was made based on evidence from Somalia and through a consultative process that brought together local health authorities, local and international partners. The new treatment, Artemisinin-based Combination Therapy (ACT) is made up of two drugs: Artesunate and Sulfadoxine- Pyramethamine. Since January 2006, UNICEF has been training health workers in the country on malaria treatment using ACT to replace drugs to which there is high resistance.

“So far more than 450 health workers from 130 public health facilities have been trained. As severely malnourished children are particularly vulnerable to malaria, ACT is also being provided through the therapeutic feeding centers. Alongside the new drugs, rapid diagnostic tests are being introduced. These simple-to-use tests can confirm Malaria diagnosis within 15 minutes and are useful where reliable testing is not available,” added Mr Balslev-Olesen.

UNICEF Somalia and its partners are ensuring that the change to ACT is implemented through the training of staff of Maternal and Child Health (MCH) centres and hospitals; development of implementation guidelines and distribution of the drugs including the malaria diagnostic tests that have been procured and delivered in Somalia. ACTs are available at public health facilities across the country.

Malaria control efforts in Somalia are funded through the Global Fund to fight AIDS, Tuberculosis and Malaria.

In 2004, the Global Fund gave Somalia a $12.8 m grant to help in malaria prevention and control. One of the main components of the grant was the provision of effective malaria treatment drugs and the strengthening of diagnostic capacity. Other activities planned included the development of a national malaria control strategy, procurement and distribution of insecticide treated nets (ITNs) to the most vulnerable, and increasing public awareness about the disease.
“About 4.6 million people among them, 966,000 children under five years of age and 230,000 pregnant women are expected to benefit through the Global Fund initiative,” said Tanya Shewchuk, the Global Fund’s Malaria Programme Officer for Somalia.

Africa Malaria Day which is commemorated annually on April 25 will mark the launch of ACTs and diagnostic tests in Somalia. To sensitize the public on the availability of the new treatment, UNICEF in collaboration with international and local NGOs is organizing public events today in different locations.


유니세프한국위원회 개요
유니세프한국위원회는 한국에서 유니세프를 대표하는 기관(비영리법인)으로서 한국위원회의 주된 임무는 세계 어린이를 위해 국내에서 세계 어린이 현황과 유니세프 활동을 널리 알려 어린이돕기 기금을 조성하는 것입니다. 또한, 아동의 권리 홍보 및 모유수유 권장, 세계교육 등의 사업을 통해 어린이 권리를 신장하는 활동도 함께 펼쳐 나갑니다. 유니세프한국위원회가 국내에서 펼치는 모든 활동은 유니세프가 전세계적으로 펼치고 있는 어린이 구호활동을 지지하기 위한 것입니다.

웹사이트: http://www.unicef.or.kr

연락처

유니세프한국위원회 홍보부 김재명 대리, 02-735-2315, 이메일 보내기